Edition:
United States

Flexion Therapeutics Inc (FLXN.OQ)

FLXN.OQ on NASDAQ Stock Exchange Global Market

18.94USD
19 Oct 2018
Change (% chg)

$0.31 (+1.66%)
Prev Close
$18.63
Open
$18.73
Day's High
$19.36
Day's Low
$18.60
Volume
202,025
Avg. Vol
167,591
52-wk High
$29.07
52-wk Low
$17.27

Chart for

About

Flexion Therapeutics, Inc. is a United States-based specialty pharmaceutical company. The Company is focused on the development and commercialization of local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis. The Company's lead product... (more)

Overall

Beta: 0.72
Market Cap(Mil.): $703.37
Shares Outstanding(Mil.): 37.82
Dividend: --
Yield (%): --

Financials

  FLXN.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -4.72 -- --
ROI: -49.31 1.96 12.83
ROE: -87.51 1.12 14.95

BRIEF-Flexion Therapeutics Q1 Loss Per Share $1.10

* FLEXION THERAPEUTICS REPORTS FIRST-QUARTER 2018 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS

May 08 2018

BRIEF-Flexion Therapeutics Names David Arkowitz As Chief Financial Officer

* FLEXION THERAPEUTICS NAMES DAVID ARKOWITZ AS CHIEF FINANCIAL OFFICER

May 07 2018

Earnings vs. Estimates